6-49606913-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_000324.3(RHAG):c.1147C>A(p.Leu383Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000722 in 1,610,196 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.00045 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00075 ( 3 hom. )
Consequence
RHAG
NM_000324.3 missense
NM_000324.3 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 4.01
Genes affected
RHAG (HGNC:10006): (Rh associated glycoprotein) The protein encoded by this gene is erythrocyte-specific and is thought to be part of a membrane channel that transports ammonium and carbon dioxide across the blood cell membrane. The encoded protein appears to interact with Rh blood group antigens and Rh30 polypeptides. Defects in this gene are a cause of regulator type Rh-null hemolytic anemia (RHN), or Rh-deficiency syndrome.[provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.06165579).
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000453 (69/152270) while in subpopulation NFE AF= 0.000853 (58/68032). AF 95% confidence interval is 0.000677. There are 0 homozygotes in gnomad4. There are 33 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 3 AD,AR,BG gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RHAG | NM_000324.3 | c.1147C>A | p.Leu383Ile | missense_variant | 9/10 | ENST00000371175.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RHAG | ENST00000371175.10 | c.1147C>A | p.Leu383Ile | missense_variant | 9/10 | 1 | NM_000324.3 | P2 | |
RHAG | ENST00000646272.1 | c.1147C>A | p.Leu383Ile | missense_variant | 9/10 | A2 | |||
RHAG | ENST00000646939.1 | c.1025C>A | p.Ser342Tyr | missense_variant | 8/9 | ||||
RHAG | ENST00000646963.1 | c.1138+237C>A | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.000453 AC: 69AN: 152152Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
69
AN:
152152
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000275 AC: 69AN: 250974Hom.: 0 AF XY: 0.000346 AC XY: 47AN XY: 135644
GnomAD3 exomes
AF:
AC:
69
AN:
250974
Hom.:
AF XY:
AC XY:
47
AN XY:
135644
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000750 AC: 1093AN: 1457926Hom.: 3 Cov.: 29 AF XY: 0.000718 AC XY: 521AN XY: 725552
GnomAD4 exome
AF:
AC:
1093
AN:
1457926
Hom.:
Cov.:
29
AF XY:
AC XY:
521
AN XY:
725552
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000453 AC: 69AN: 152270Hom.: 0 Cov.: 33 AF XY: 0.000443 AC XY: 33AN XY: 74454
GnomAD4 genome
AF:
AC:
69
AN:
152270
Hom.:
Cov.:
33
AF XY:
AC XY:
33
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
3
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
4
ExAC
AF:
AC:
33
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Sep 27, 2023 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The RHAG p.Leu383Ile variant was not identified in the literature nor was it identified in ClinVar. The variant was identified in dbSNP (ID: rs141051794) and in control databases in 85 of 282380 chromosomes at a frequency of 0.000301 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: European (non-Finnish) in 77 of 128868 chromosomes (freq: 0.000598), European (Finnish) in 5 of 25096 chromosomes (freq: 0.000199), Other in 1 of 7204 chromosomes (freq: 0.000139) and African in 2 of 24960 chromosomes (freq: 0.00008), but was not observed in the Latino, Ashkenazi Jewish, East Asian, or South Asian populations. The p.Leu383 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2022 | The c.1147C>A (p.L383I) alteration is located in exon 9 (coding exon 9) of the RHAG gene. This alteration results from a C to A substitution at nucleotide position 1147, causing the leucine (L) at amino acid position 383 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
T;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;.
MutationTaster
Benign
D;N
PrimateAI
Benign
T
PROVEAN
Benign
N;.;.
REVEL
Benign
Sift
Uncertain
D;.;.
Sift4G
Benign
T;.;T
Polyphen
P;.;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at